Page 524 Acute Pain Management
P. 524

 




nsNSAID
 non‐selective
non‐steroidal
anti‐inflammatory
drug

OIH
 opioid‐induced
hyperalgesia

OR

 odds
ratio

OSA
 obstructive
sleep
apnoea

OTC
 over‐the‐counter

OTFC
 oral
transmucosal
fentanyl
citrate

P 2X 3
 purinergic
receptor
subtype

PACSLAC
 Pain
Assessment
Checklist
for
Seniors
with
Limited
Ability
to
Communicate

PACU
 postanaesthesia
care
unit


PAINAD
 Pain
Assessment
in
Advanced
Dementia

PAR
 proteinase‐activated
receptor

PCA
 patient‐controlled
analgesia

PCEA
 patient‐controlled
epidural
analgesia

PCINA
 patient‐controlled
intranasal
analgesia

PCRA
 patient‐controlled
regional
analgesia


PCS
 Pain
Catastrophising
Scale

PCTS
 patient‐controlled
transdermal
system

PDPH
 post‐dural
puncture
headache

PG‐BA
 polyethylene
glycol
and
benzyl
alcohol

PGE 2
 prostaglandin
E2

PGH
 prostaglandin
endoperoxide

PGI 2
 prostacyclin

PHN
 post‐herpetic
neuralgia

PIPP
 premature
infant
pain
profile

PNB
 peripheral
nerve
block

PNS
 peripheral
nerve
stimulator

POCD
 postoperative
cognitive
dysfunction

PONV
 postoperative
nausea
and
vomiting

PPI
 proton
pump
inhibitor

PPP
 Paediatric
Pain
Profile

PPPM
 Parents
Postoperative
Pain
Measure

PTA
 Polymyxin
E,
tobramycin
and
amphotericin
B

quality
of
life

QOL

ABBREVIATIONS
 RADARS
 Researched
Abuse,
Diversion
and
Addiction‐Related
Surveillance

quantitative
sensory
testing

QST

RCT

randomised
controlled
trial

rESS

revised
Edmonton
Staging
System

ribonucleic
acid

RNA

RR

RVM
 relative
risk

rostroventromedial
medulla

476
 Acute
Pain
Management:
Scientific
Evidence

   519   520   521   522   523   524   525   526   527   528   529